Sangamo BioSciences | SGMO - Market Capitalization


Sangamo BioSciences reported $32.7M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Amgen USD 195.44B 5.55B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Cipla INR 1.18T 194.93B Jun/2026
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.29M 475.62M Mar/2026
CSL USD 55.89B 20.42B Dec/2025
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026